The consequences of this high CD39 activity in endometrial tumors are increased levels of AMP, the substrate for CD73, and also highly expressed in these tumors, which will, in turn, generate increased immunosuppressive levels of extracellular adenosine. This evidence concerns the gene NT5E and endometrium neoplasm.